Indivior stock gains on merger and special dividend
Published on 09/11/2026 at 13:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Indivior stock (GB00BYZ0C031) traded at USD 34.51 on September 11, 2026, with a market capitalization of USD 4.07 billion and a 52-week range of USD 22.22 to USD 42.81. The latest catalyst was the merger with Supernus and the special dividend plan, which ad hoc news reported on September 10, 2026.
Consensus stays supportive
According to MarketBeat on September 11, 2026, Indivior has an average rating of Moderate Buy and an average target price of USD 45.17. The same report says six analysts rate the stock Buy and one rates it Hold, while Barclays cut its target from USD 46.00 to USD 43.00 and Weiss Ratings raised the stock from Hold (c+) to Buy (b-) on September 4, 2026.
That gives investors a concrete benchmark: the consensus target of USD 45.17 sits 30.0 percent above the Nasdaq price of USD 34.51. Craig Hallum still kept a Buy rating with a USD 53.00 target on August 4, 2026, according to the same MarketBeat filing.
June quarter still matters
MarketBeat said Indivior last announced quarterly earnings on June 30, 2026, when it reported EPS of USD 5.75 and revenue of USD 343.0 million. The same filing also cited a net margin of 26.65 percent and a negative return on equity of 283.11 percent.
Those figures frame the stock split between valuation support and operating risk. Sell-side analysts on average now forecast USD 3.66 earnings per share for the current fiscal year, according to the same MarketBeat filing on September 11, 2026.
Stock near its range
Indivior shares opened at USD 34.51 on September 11, 2026, which leaves the stock 19.4 percent below the 52-week high of USD 42.81 and 55.2 percent above the 52-week low of USD 22.22. For now, the range and the USD 4.07 billion market value matter more than a clean break above the recent trading band.
Indivior stock facts
- Company: Indivior PLC
- ISIN: GB00BYZ0C031
- Ticker: INDV
- Trading venue: NASDAQ
- Price (as of September 11, 2026): USD 34.51
- Market capitalization: USD 4.07 billion (as of September 11, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
- Index membership: None found in the available sources
